WGU D115 OA AND PRE -ASSESSMENT LATEST 2026/2027
TEST BANK| WGU D115 ADVANCED PATHOPHYSIOLOGY
OA & PA TEST BANK (BRAND NEW!!) — 200 Questions and
Answers Already Graded A+ Premium Exam Tested And
Verified
Subject Area Advanced Pathophysiology
Description This examination assesses the student's ability to integrate molecular, cellular, and
systemic pathophysiologic mechanisms underlying major human diseases.
Emphasis is placed on clinical reasoning, interpretation of diagnostic data, and
understanding of therapeutic implications at an Ivy League graduate level.
Expected Grade A+
Total Questions 200
Duration 3 hours
Learning Outcomes 1. Analyze the interplay of genetic, epigenetic, and environmental factors in
disease pathogenesis.
2. Evaluate the molecular mechanisms of cellular injury, adaptation, and death in
various disease states.
3. Synthesize pathophysiologic concepts to explain clinical manifestations and
diagnostic findings.
4. Critically appraise the rationale for current and emerging therapeutic strategies
based on disease mechanisms.
Accreditation This exam adheres to the rigorous standards of top-tier US research universities
(e.g., Harvard, Stanford, MIT) and reflects the depth expected in a capstone
advanced pathophysiology course.
Page 1
,1. In a patient with a gain-of-function mutation in the calcium-sensing receptor
(CaSR) that increases its sensitivity to extracellular calcium, which compensatory
renal response is MOST likely to be impaired?
A. Increased reabsorption of calcium in the distal convoluted tubule
B. Decreased synthesis of 1,25-dihydroxyvitamin D
C. Increased urinary excretion of phosphate
D. Decreased expression of klotho in the proximal tubule
Answer: B. Decreased synthesis of 1,25-dihydroxyvitamin D
The mutant CaSR signals a falsely high calcium level, suppressing PTH secretion. PTH
normally stimulates 1±-hydroxylase to produce active vitamin D. Without PTH,
1,25-dihydroxyvitamin D synthesis is reduced. Option A is incorrect because PTH
increases calcium reabsorption; without PTH, reabsorption decreases. Option C is
incorrect because PTH increases phosphate excretion; without PTH, phosphate
excretion decreases. Option D is unrelated to the immediate compensatory response.
2. A researcher is studying a novel compound that inhibits the interaction between
p53 and MDM2. Which of the following cellular outcomes would be MOST
consistent with the compound's mechanism in a cell line with wild-type p53?
A. Increased degradation of p53 via the proteasome
B. Decreased transcription of p21 and BAX
C. Arrest in G1 phase of the cell cycle and induction of apoptosis
D. Enhanced nuclear export of p53
Answer: C. Arrest in G1 phase of the cell cycle and induction of apoptosis
MDM2 binds p53 and targets it for ubiquitination and proteasomal degradation.
Inhibiting this interaction stabilizes p53, leading to increased transcription of p21 (cell
cycle arrest) and BAX (apoptosis). Option A is opposite; Option B is opposite; Option D
is incorrect because nuclear export of p53 is mediated by MDM2, and inhibition would
reduce export.
Page 2
,3. In a patient with chronic heart failure, which combination of neurohormonal
adaptations is MOST likely to contribute to the progression of left ventricular
dysfunction?
A. Increased sympathetic activity and increased natriuretic peptide secretion
B. Increased renin-angiotensin-aldosterone system activity and decreased vasopressin release
C. Increased sympathetic activity and increased endothelin-1 expression
D. Decreased sympathetic activity and increased nitric oxide bioavailability
Answer: C. Increased sympathetic activity and increased endothelin-1 expression
Chronic heart failure leads to sustained sympathetic activation and increased
endothelin-1, both of which promote vasoconstriction, afterload increase, and direct
myocardial toxicity, worsening ventricular function. Option A: natriuretic peptides are
compensatory and beneficial. Option B: vasopressin is typically increased, not
decreased. Option D: sympathetic activity is increased, and nitric oxide bioavailability
is decreased.
4. A 45-year-old individual with a history of recurrent thromboembolism is found to
have a plasma homocysteine level of 45 ¼mol/L (normal <15). Which of the following
best explains the mechanism by which hyperhomocysteinemia promotes thrombosis?
A. Increased synthesis of prostacyclin (PGI2) by endothelial cells
B. Inhibition of antithrombin III activity
C. Impaired generation of activated protein C
D. Enhanced expression of thrombomodulin on endothelial cells
Answer: C. Impaired generation of activated protein C
Hyperhomocysteinemia causes oxidative stress that damages endothelium, reducing
thrombomodulin expression and impairing protein C activation. This shifts the balance
toward thrombosis. Option A is incorrect because PGI2 is anti-thrombotic and its
synthesis is decreased. Option B: antithrombin III is not directly inhibited by
homocysteine. Option D: thrombomodulin expression is decreased, not enhanced.
Page 3
, 5. In a patient with chronic kidney disease (stage 4), which of the following
laboratory findings is MOST indicative of renal osteodystrophy due to secondary
hyperparathyroidism?
A. Low serum calcium, low serum phosphate, elevated 1,25-dihydroxyvitamin D
B. Low serum calcium, high serum phosphate, low 1,25-dihydroxyvitamin D
C. High serum calcium, high serum phosphate, elevated PTH
D. Normal serum calcium, low serum phosphate, elevated fibroblast growth factor 23
Answer: B. Low serum calcium, high serum phosphate, low 1,25-dihydroxyvitamin
D
In CKD, phosphate retention and decreased 1±-hydroxylase activity lead to low
1,25-dihydroxyvitamin D, causing hypocalcemia and secondary hyperparathyroidism.
Option A is incorrect because phosphate is high, not low, and vitamin D is low. Option
C is incorrect because calcium is low, not high. Option D describes early CKD with
FGF23 elevation but is not the classic pattern of established secondary
hyperparathyroidism.
6. Which of the following best explains why mutations in the CFTR gene that result
in defective chloride transport lead to thick, dehydrated mucus in the airways?
A. Impaired bicarbonate secretion reduces the solubility of mucins
B. Increased sodium absorption via ENaC reduces airway surface liquid volume
C. Decreased chloride secretion leads to compensatory potassium efflux
D. Accumulation of chloride in epithelial cells causes osmotic swelling and mucus retention
Answer: B. Increased sodium absorption via ENaC reduces airway surface liquid
volume
In cystic fibrosis, defective CFTR prevents chloride secretion, and ENaC activity is
increased, leading to excessive sodium and water absorption from the airway surface
liquid, dehydrating the mucus. Option A: bicarbonate secretion is also impaired but is
not the primary cause of dehydration. Option C: potassium efflux is not a major
compensatory mechanism. Option D: chloride does not accumulate; it is not secreted.
Page 4
TEST BANK| WGU D115 ADVANCED PATHOPHYSIOLOGY
OA & PA TEST BANK (BRAND NEW!!) — 200 Questions and
Answers Already Graded A+ Premium Exam Tested And
Verified
Subject Area Advanced Pathophysiology
Description This examination assesses the student's ability to integrate molecular, cellular, and
systemic pathophysiologic mechanisms underlying major human diseases.
Emphasis is placed on clinical reasoning, interpretation of diagnostic data, and
understanding of therapeutic implications at an Ivy League graduate level.
Expected Grade A+
Total Questions 200
Duration 3 hours
Learning Outcomes 1. Analyze the interplay of genetic, epigenetic, and environmental factors in
disease pathogenesis.
2. Evaluate the molecular mechanisms of cellular injury, adaptation, and death in
various disease states.
3. Synthesize pathophysiologic concepts to explain clinical manifestations and
diagnostic findings.
4. Critically appraise the rationale for current and emerging therapeutic strategies
based on disease mechanisms.
Accreditation This exam adheres to the rigorous standards of top-tier US research universities
(e.g., Harvard, Stanford, MIT) and reflects the depth expected in a capstone
advanced pathophysiology course.
Page 1
,1. In a patient with a gain-of-function mutation in the calcium-sensing receptor
(CaSR) that increases its sensitivity to extracellular calcium, which compensatory
renal response is MOST likely to be impaired?
A. Increased reabsorption of calcium in the distal convoluted tubule
B. Decreased synthesis of 1,25-dihydroxyvitamin D
C. Increased urinary excretion of phosphate
D. Decreased expression of klotho in the proximal tubule
Answer: B. Decreased synthesis of 1,25-dihydroxyvitamin D
The mutant CaSR signals a falsely high calcium level, suppressing PTH secretion. PTH
normally stimulates 1±-hydroxylase to produce active vitamin D. Without PTH,
1,25-dihydroxyvitamin D synthesis is reduced. Option A is incorrect because PTH
increases calcium reabsorption; without PTH, reabsorption decreases. Option C is
incorrect because PTH increases phosphate excretion; without PTH, phosphate
excretion decreases. Option D is unrelated to the immediate compensatory response.
2. A researcher is studying a novel compound that inhibits the interaction between
p53 and MDM2. Which of the following cellular outcomes would be MOST
consistent with the compound's mechanism in a cell line with wild-type p53?
A. Increased degradation of p53 via the proteasome
B. Decreased transcription of p21 and BAX
C. Arrest in G1 phase of the cell cycle and induction of apoptosis
D. Enhanced nuclear export of p53
Answer: C. Arrest in G1 phase of the cell cycle and induction of apoptosis
MDM2 binds p53 and targets it for ubiquitination and proteasomal degradation.
Inhibiting this interaction stabilizes p53, leading to increased transcription of p21 (cell
cycle arrest) and BAX (apoptosis). Option A is opposite; Option B is opposite; Option D
is incorrect because nuclear export of p53 is mediated by MDM2, and inhibition would
reduce export.
Page 2
,3. In a patient with chronic heart failure, which combination of neurohormonal
adaptations is MOST likely to contribute to the progression of left ventricular
dysfunction?
A. Increased sympathetic activity and increased natriuretic peptide secretion
B. Increased renin-angiotensin-aldosterone system activity and decreased vasopressin release
C. Increased sympathetic activity and increased endothelin-1 expression
D. Decreased sympathetic activity and increased nitric oxide bioavailability
Answer: C. Increased sympathetic activity and increased endothelin-1 expression
Chronic heart failure leads to sustained sympathetic activation and increased
endothelin-1, both of which promote vasoconstriction, afterload increase, and direct
myocardial toxicity, worsening ventricular function. Option A: natriuretic peptides are
compensatory and beneficial. Option B: vasopressin is typically increased, not
decreased. Option D: sympathetic activity is increased, and nitric oxide bioavailability
is decreased.
4. A 45-year-old individual with a history of recurrent thromboembolism is found to
have a plasma homocysteine level of 45 ¼mol/L (normal <15). Which of the following
best explains the mechanism by which hyperhomocysteinemia promotes thrombosis?
A. Increased synthesis of prostacyclin (PGI2) by endothelial cells
B. Inhibition of antithrombin III activity
C. Impaired generation of activated protein C
D. Enhanced expression of thrombomodulin on endothelial cells
Answer: C. Impaired generation of activated protein C
Hyperhomocysteinemia causes oxidative stress that damages endothelium, reducing
thrombomodulin expression and impairing protein C activation. This shifts the balance
toward thrombosis. Option A is incorrect because PGI2 is anti-thrombotic and its
synthesis is decreased. Option B: antithrombin III is not directly inhibited by
homocysteine. Option D: thrombomodulin expression is decreased, not enhanced.
Page 3
, 5. In a patient with chronic kidney disease (stage 4), which of the following
laboratory findings is MOST indicative of renal osteodystrophy due to secondary
hyperparathyroidism?
A. Low serum calcium, low serum phosphate, elevated 1,25-dihydroxyvitamin D
B. Low serum calcium, high serum phosphate, low 1,25-dihydroxyvitamin D
C. High serum calcium, high serum phosphate, elevated PTH
D. Normal serum calcium, low serum phosphate, elevated fibroblast growth factor 23
Answer: B. Low serum calcium, high serum phosphate, low 1,25-dihydroxyvitamin
D
In CKD, phosphate retention and decreased 1±-hydroxylase activity lead to low
1,25-dihydroxyvitamin D, causing hypocalcemia and secondary hyperparathyroidism.
Option A is incorrect because phosphate is high, not low, and vitamin D is low. Option
C is incorrect because calcium is low, not high. Option D describes early CKD with
FGF23 elevation but is not the classic pattern of established secondary
hyperparathyroidism.
6. Which of the following best explains why mutations in the CFTR gene that result
in defective chloride transport lead to thick, dehydrated mucus in the airways?
A. Impaired bicarbonate secretion reduces the solubility of mucins
B. Increased sodium absorption via ENaC reduces airway surface liquid volume
C. Decreased chloride secretion leads to compensatory potassium efflux
D. Accumulation of chloride in epithelial cells causes osmotic swelling and mucus retention
Answer: B. Increased sodium absorption via ENaC reduces airway surface liquid
volume
In cystic fibrosis, defective CFTR prevents chloride secretion, and ENaC activity is
increased, leading to excessive sodium and water absorption from the airway surface
liquid, dehydrating the mucus. Option A: bicarbonate secretion is also impaired but is
not the primary cause of dehydration. Option C: potassium efflux is not a major
compensatory mechanism. Option D: chloride does not accumulate; it is not secreted.
Page 4
